COMMUNIQUÉ DE PRESSE publié le 15/07/2024 à 08:15, il y a 2 années Nyxoah Appoints Scott Holstine as Chief Commercial Officer Nyxoah appoints Scott Holstine as Chief Commercial Officer, bringing 26 years of medical device industry experience. His role is crucial for Nyxoah's U.S. launch success in treating Obstructive Sleep Apnea Chief Commercial Officer Medical Technology Nyxoah Obstructive Sleep Apnea Scott Holstine
BRÈVE publiée le 03/07/2024 à 12:35, il y a 2 années 1 mois Nyxoah signe un accord de prêt de 37,5 millions d'euros avec la Banque européenne d'investissement Technologie Médicale Accord De Prêt Banque Européenne D'investissement Nyxoah Apnée Obstructive Du Sommeil
BRÈVE publiée le 03/07/2024 à 12:35, il y a 2 années 1 mois Nyxoah Signs €37.5 Million Loan Agreement with European Investment Bank Loan Agreement Medical Technology European Investment Bank Nyxoah Obstructive Sleep Apnea
COMMUNIQUÉ DE PRESSE publié le 03/07/2024 à 12:30, il y a 2 années 1 mois Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Nyxoah signs a €37.5 million loan facility agreement with the European Investment Bank to boost research, development, and manufacturing capacity for sleep apnea solutions Research And Development European Investment Bank Sleep Apnea Nyxoah €37.5 Million Loan
Publié le 10/08/2026 à 11:53, il y a 3 heures 15 minutes GUILLEMOT CORPORATION | Information regarding the total number of voting rights and shares 31/07/2026
Publié le 10/08/2026 à 11:53, il y a 3 heures 15 minutes GUILLEMOT CORPORATION |Informations relatives au nombre total de droits de vote et d’actions 31/07/2026
Publié le 10/08/2026 à 11:36, il y a 3 heures 32 minutes GUILLEMOT CORPORATION| Weekly report share buyback from August 3 to August 7 2026
Publié le 10/08/2026 à 11:36, il y a 3 heures 32 minutes GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 3 au 7 août 2026
Publié le 10/08/2026 à 09:47, il y a 5 heures 21 minutes 260810 BENETEAU Transactions sur actions propres
Publié le 10/08/2026 à 14:30, il y a 39 minutes NanoViricides Has Received Regulatory Approval for a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo To Fight the Current Largest Ever and Expanding Ebola Outbreak
Publié le 10/08/2026 à 13:30, il y a 1 heure 39 minutes Sterling Expands High-Grade Copper Mineralization East at MEPS Intersecting 203 Metres at 0.51% CuEq: Includes 16.25 Metres at 2.31% CuEq and 9.50 Metres at 2.34% CuEq within 445 Metres at 0.40% CuEq
Publié le 10/08/2026 à 13:00, il y a 2 heures 9 minutes Alaska Energy Metals Announces Drilling Program for the Mcbride Prospect, Angliers-Belleterre Project, Quebec, Canada
Publié le 10/08/2026 à 13:00, il y a 2 heures 9 minutes Azarga Metals Mobilizes Drill Rig and Ancillary Equipment to Marg Project, Yukon
Publié le 10/08/2026 à 13:00, il y a 2 heures 9 minutes NioCorp to Host Webcast on Aug. 11 to Discuss Elk Creek Feasibility Study Results
Publié le 10/08/2026 à 14:35, il y a 33 minutes Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.81 Million Tokens, and Total Crypto and Total Cash Holdings of $11.6 Billion
Publié le 10/08/2026 à 14:31, il y a 37 minutes Heimo Scheuch decides to resign early as CEO of wienerberger for personal health reasons, Gerhard Hanke appointed Interim CEO
Publié le 10/08/2026 à 14:30, il y a 39 minutes Fitch Ratings upgrades outlook for Fresenius SE from stable to positive
Publié le 10/08/2026 à 14:25, il y a 44 minutes EQS-Adhoc: Ad hoc: Heimo Scheuch decides to resign early as CEO of wienerberger for personal health reasons, Gerhard Hanke appointed Interim CEO
